Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takeshi Masuda

Showing results (151-160 of 298) with videos related to

Pageof 30
Sort By:
Oncotarget|December 8, 2017
<i>AGER</i> rs2070600 polymorphism elevates neutrophil-lymphocyte ratio and mortality in metastatic lung adenocarcinomaKakuhiro Yamaguchi, Hiroshi Iwamoto, Shinjiro Sakamoto, et al.
Medicine|March 22, 2019
Cerebral embolism during edoxaban administration for venous thromboembolism in a patient with lung adenocarcinoma: A case reportSatoshi Nakao, Takeshi Masuda, Shinjiro Sakamoto, et al.
Iscience|December 17, 2024
Increased CSN5 expression enhances the sensitivity to lenalidomide in multiple myeloma cellsTakumi Yamamoto, Arisu Furukawa, Yue Zhou, et al.
Lung|March 13, 2025
Serum Soluble Toll-Like Receptor 4 is a Predictive Biomarker for Acute Exacerbation and Prognosis of Idiopathic Pulmonary Fibrosis: A Retrospective StudyErika Kitadai, Kakuhiro Yamaguchi, Hiroshi Iwamoto, et al.
Respiratory Research|May 4, 2024
Lipocalin-2 as a prognostic marker in patients with acute exacerbation of idiopathic pulmonary fibrosisHiroki Tanahashi, Hiroshi Iwamoto, Kakuhiro Yamaguchi, et al.
Cell Communication and Signaling : CCS|September 22, 2023
Nestin and Notch3 collaboratively regulate angiogenesis, collagen production, and endothelial-mesenchymal transition in lung endothelial cellsWakako Daido, Taku Nakashima, Takeshi Masuda, et al.
The Journal of Biological Chemistry|June 8, 2014
Characterization of genomic deletion efficiency mediated by clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 nuclease system in mammalian cellsMatthew C Canver, Daniel E Bauer, Abhishek Dass, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 6, 2023
G protein-biased LPAR1 agonism of prototypic antidepressants: Implication in the identification of novel therapeutic target for depressionNaoto Kajitani, Mami Okada-Tsuchioka, Asuka Inoue, et al.
Clinical Lung Cancer|January 1, 2025
A Phase II, Open Label, Single-Arm Study on the Efficacy of Cabozantinib in Patients With Advanced/Metastatic Nonsmall Cell Lung Cancer Harboring MET Exon 14 Alterations who Developed Acquired Resistance to Tepotinib or Capmatinib (CAPTURE Trial)Masayuki Takeda, Masahide Ota, Eiji Iwama, et al.
Respiratory Medicine|September 10, 2020
Serum high-mobility group box 1 as a predictive marker for cytotoxic chemotherapy-induced lung injury in patients with lung cancer and interstitial lung diseaseSatoshi Nakao, Kakuhiro Yamaguchi, Hiroshi Iwamoto, et al.
Pageof 30

Showing results (151-160 of 298) with videos related to

Sort By:
Pageof 30
Oncotarget|December 8, 2017
<i>AGER</i> rs2070600 polymorphism elevates neutrophil-lymphocyte ratio and mortality in metastatic lung adenocarcinomaKakuhiro Yamaguchi, Hiroshi Iwamoto, Shinjiro Sakamoto, et al.
Medicine|March 22, 2019
Cerebral embolism during edoxaban administration for venous thromboembolism in a patient with lung adenocarcinoma: A case reportSatoshi Nakao, Takeshi Masuda, Shinjiro Sakamoto, et al.
Iscience|December 17, 2024
Increased CSN5 expression enhances the sensitivity to lenalidomide in multiple myeloma cellsTakumi Yamamoto, Arisu Furukawa, Yue Zhou, et al.
Lung|March 13, 2025
Serum Soluble Toll-Like Receptor 4 is a Predictive Biomarker for Acute Exacerbation and Prognosis of Idiopathic Pulmonary Fibrosis: A Retrospective StudyErika Kitadai, Kakuhiro Yamaguchi, Hiroshi Iwamoto, et al.
Respiratory Research|May 4, 2024
Lipocalin-2 as a prognostic marker in patients with acute exacerbation of idiopathic pulmonary fibrosisHiroki Tanahashi, Hiroshi Iwamoto, Kakuhiro Yamaguchi, et al.
Cell Communication and Signaling : CCS|September 22, 2023
Nestin and Notch3 collaboratively regulate angiogenesis, collagen production, and endothelial-mesenchymal transition in lung endothelial cellsWakako Daido, Taku Nakashima, Takeshi Masuda, et al.
The Journal of Biological Chemistry|June 8, 2014
Characterization of genomic deletion efficiency mediated by clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 nuclease system in mammalian cellsMatthew C Canver, Daniel E Bauer, Abhishek Dass, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 6, 2023
G protein-biased LPAR1 agonism of prototypic antidepressants: Implication in the identification of novel therapeutic target for depressionNaoto Kajitani, Mami Okada-Tsuchioka, Asuka Inoue, et al.
Clinical Lung Cancer|January 1, 2025
A Phase II, Open Label, Single-Arm Study on the Efficacy of Cabozantinib in Patients With Advanced/Metastatic Nonsmall Cell Lung Cancer Harboring MET Exon 14 Alterations who Developed Acquired Resistance to Tepotinib or Capmatinib (CAPTURE Trial)Masayuki Takeda, Masahide Ota, Eiji Iwama, et al.
Respiratory Medicine|September 10, 2020
Serum high-mobility group box 1 as a predictive marker for cytotoxic chemotherapy-induced lung injury in patients with lung cancer and interstitial lung diseaseSatoshi Nakao, Kakuhiro Yamaguchi, Hiroshi Iwamoto, et al.
Pageof 30